CHI HEALTH PLAINVIEW HOSPITAL

45 CFR § 180 compliance

A · 100

This hospital published most of what § 180 requires.

●Machine-readable file published

●Gross / standard charges

●Discounted cash price

●Payer-specific negotiated rates

●Min / max negotiated charges

●Free, public, no login required

Procedures listed

10,227

Insurances with rates

CPT / HCPCS codes

7,404

Source MRF

json ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$501,274	$538,571	$584,820	19
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$501,274	$364,021	$808,126	32
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$199,500	$214,344	$232,750	19
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$199,500	$144,875	$321,623	32
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$183,400	$197,046	$213,966	19
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$183,400	$133,183	$295,667	32
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$173,384	$186,285	$202,281	19
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$173,384	$125,910	$279,520	32
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$172,931	$185,798	$201,753	19
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$172,931	$125,581	$278,789	32
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$149,137	$160,233	$173,993	19
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$149,137	$108,302	$240,430	32
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$107,379	$115,369	$125,276	19
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$107,379	$77,978	$173,111	32
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$90,720	$97,470	$105,840	19
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$90,720	$65,880	$146,254	32
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$82,800	$88,961	$96,600	19
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$82,800	$60,129	$133,486	32
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$75,891	$81,538	$88,540	19
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$75,891	$55,111	$122,347	32
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$71,920	$77,271	$83,906	19
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$71,920	$52,227	$115,945	32
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$66,247	$71,176	$77,288	19
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$66,247	$48,108	$106,799	32
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$64,981	$69,816	$75,811	19
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$64,981	$47,188	$104,758	32
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$64,621	$69,429	$75,391	19
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$64,621	$46,927	$104,179	32
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$61,036	$65,578	$71,209	19
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$61,036	$44,324	$98,399	32
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$59,038	$63,430	$68,877	19
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$59,038	$42,873	$95,177	32
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$55,935	$60,097	$65,257	19
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$55,935	$40,619	$90,175	32
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$50,801	$54,581	$59,268	19
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$50,801	$36,891	$81,898	32
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$49,316	$52,986	$57,536	19
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$49,316	$35,813	$79,505	32
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$47,613	$51,155	$55,548	19
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$47,613	$34,576	$76,759	32
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$47,423	$50,952	$55,327	19
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$47,423	$34,438	$76,453	32
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$47,258	$50,774	$55,134	19
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$47,258	$34,318	$76,186	32
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$45,950	$49,369	$53,608	19
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$45,950	$33,369	$74,078	32
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$44,180	$47,467	$51,543	19
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$44,180	$32,083	$71,224	32
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$43,985	$47,257	$51,315	19
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$43,985	$31,941	$70,909	32

Showing top 50 of 10,227 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.